View More Recent Stories

Sep 9, 2024 04:20PM Ionis Pharmaceuticals (IONS) Announces Proposed $500M Share Offering
Sep 4, 2024 07:32AM Biogen (BIIB) Reports Positive Topline Results from Study of Higher Dose Regimen of Nusinersen
Aug 2, 2024 03:09AM BMO Capital Downgrades Ionis Pharmaceuticals (IONS) to Market Perform
Aug 1, 2024 07:12AM Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 48c
Jul 30, 2024 07:17AM RBC's biotech survey shows investors more bearish vs. last time
Jul 24, 2024 06:54AM Leerink Partners Upgrades Ionis Pharmaceuticals (IONS) to Outperform
Jul 23, 2024 09:10AM Ionis Pharmaceuticals (IONS) PT Raised to $59 at TD Cowen
Jul 23, 2024 08:57AM BMO Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
Jul 22, 2024 01:06PM Ionis Pharmaceuticals (IONS) PT Raised to $77 at Jefferies
Jul 22, 2024 12:04PM Goldman Sachs Reiterates Sell Rating on Ionis Pharmaceuticals (IONS)
Jul 22, 2024 07:03AM Ionis Pharmaceuticals (IONS) announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome
Jul 16, 2024 08:06AM Jefferies Double Upgrades Ionis Pharmaceuticals (IONS) to Buy
Jun 27, 2024 08:12AM Ionis Pharmaceuticals (IONS) PT Raised to $53 at Stifel
Jun 25, 2024 06:55AM Ionis Pharmaceuticals (IONS) announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
Jun 24, 2024 02:08PM TD Cowen Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
Jun 24, 2024 07:58AM Alnylam (ALNY) data is positive for Ionis (IONS), Intellia (NTLA) and negative for BridgeBio (BBIO) - analyst
Jun 18, 2024 07:04AM Ionis Pharmaceuticals (IONS) expanded licensing agreement with Otsuka in Asia Pacific for investigational medicine donidalorsen in hereditary angioedema
Jun 17, 2024 06:22AM RBC Capital Reiterates Outperform Rating on Ionis Pharmaceuticals (IONS)
Jun 14, 2024 05:56AM Bernstein SocGen Group Upgrades Ionis Pharmaceuticals (IONS) to Market Perform
View More Recent Stories